Found vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Visit Found - published $129/mo; total not verified →or find your match

Willow beats Found overall, scoring 7.5/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Found is published $129/mo; total not verified; Willow is from $299/mo. Choose Found for insured patients who want their glp-1 coverage checked and t. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side look at Found and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Found

#31 of 54

7.3/10

Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.

Visit Found

Higher Rated

Willow

#20 of 54

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Found	Willow
Why each one	One of the only GLP-1 platforms that actively coordinates with insurance companies, offers a GLP-1 coverage check, and prescribes from 10+ medications.	One of the few compounded-only platforms offering both injectable and daily oral semaglutide tablets, useful for users who want a non-injectable option without leaving the GLP-1 compounded category.
Our Score	7.3/10	7.5/10
Headline Price	published $129/mo; total not verified	from $299/mo
Medication Type	Both	Compounded
Insurance Accepted	Yes	No
Best For	Insured patients who want their GLP-1 coverage checked and their copay minimized	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Watch out for	Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying	Compounded-only, no brand-name Wegovy or Zepbound through the platform
Ranking	#31	#20
Get started	Visit Found	Visit Willow

Pros & Cons Compared

Found

Pros

+Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
+10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
+Typical insured copay of ~$30/mo for most members, dramatically lower than cash-pay alternatives
+Most members start treatment within one week of completing the health questionnaire

Cons

−Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying
−The insurance navigation process adds steps compared to simple cash-pay platforms; the payoff is the ~$30 typical copay
−Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Found with a score of 7.5/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Found is published $129/mo; total not verified; Willow is from $299/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Found if you want: insured patients who want their glp-1 coverage checked and their copay minimized. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.